Attention-deficit hyperactivity disorder: Critical appraisal of extended treatment studies

Canadian Journal of Psychiatry

Volumn 47, Issue 4, 2002, Pages 337-348

  Schachar, Russell ^a   Jadad, Alejandro R ^a   Gauld, Mary ^a   Boyle, Michael ^a   Booker, Lynda ^a   Snider, Anne ^a   Kim, Marie ^a   Cunningham, Charles ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

ADHD; Attention deficit hyperactivity disorder; Behavioural therapy; Stimulants; Systematic review; Treatment

Indexed keywords

DEXAMPHETAMINE; LITHIUM CARBONATE; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT; THIORIDAZINE;

ACADEMIC ACHIEVEMENT; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CHILD DEVELOPMENT; COGNITIVE DEVELOPMENT; COGNITIVE THERAPY; FEEDBACK SYSTEM; FOLLOW UP; HUMAN; OUTCOMES RESEARCH; REVIEW; SOCIAL ADAPTATION;

EID: 0036302876     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370204700404     Document Type: Review

References (60)

1. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents
2. Behavior problems in preschool children: A review of recent research
3. Young adult outcome of hyperactive children who received long-term stimulant treatment
4. Long-term outcome of hyperactive children: A review
5. Comorbidity in ADHD: Implications for research, practice, and DSM-V
6. Adult psychiatric status of hyperactive boys grown up
7. The treatment of attention-deficit hyperactivity disorder: An annoted bibliography and critical appraisal of published systematic reviews and meta-analyses
8. The Effects of school-based interventions for attention deficit hyperactivity disorder: A meta-analysis
9. The efficacy of stimulant drug treatment for hyperactivity: A meta-analysis
10. Hyperactivity and diet treatment: A meta-analysis of the Feingold hypothesis
11. Error patterns on the continuous performance test in nonmedicated and medicated samples of children with and without ADHD
12. Drug treatment of hyperactivity in children
13. Childhood hyperactivity and psychostimulants: A review of extended treatment studies
14. Pemoline-associated hepatic failure: A critical analysis of the literature
15. Carbamazepine use in children and adolescents with features of attention-deficit hyperactivity disorder: A meta-analysis
16. Pharmacotherapy of attention-deficit hyperactivity disorder across the life
17. Behavioral and cognitive effects of methylxanthines. A meta-analysis of theophylline and caffeine
18. Medication and hyperactivity: A meta-analysis
19. Pharmacotherapy of adult attention deficit/hyperactivity disorder: A review
20. Methylphenidate and cognitive therapy: A comparison of treatment approaches with hyperactive boys
21. Methylphenidate and cognitive therapy with ADD children: A methodological reconsideration
22. Patterns of compliance in a treatment program for children with attention deficit disorder
23. Effects of amphetamine therapy and prescriptive tutoring on the behavior and achievement of lower class hyperactive children
24. Attention deficit hyperactivity disorder: Does cognitive behavioral therapy improve home behavior?
25. Vicissitudes of follow-up studies: Differential effects of parent training and stimulant medication with hyperactives
26. Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial
27. Comparative effects of methylphenidate and thioridazine in hyperkinetic children. I. Clinical results
28. Lithium carbonate in the treatment of hyperactive children
29. Effects of methylphenidate dosage in hyperactive reading-disabled children: I. Behavior and cognitive performance effects
30. A controlled study of the effects of EEG biofeedback on cognition and behavior of children with attention deficit disorder and learning disabilities
31. 14-Month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder
32. One-year follow-up of hyperactive boys treated with imipramine or methylphenidate
33. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate
34. The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study
35. Does blinding of readers affect the results of meta-analyzes?
36. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
37. Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyzes?
38. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
39. Influences on the quality of published drug trials
40. The quality of drug studies published in symposium proceedings
41. Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviours
42. The clinical significance of neurocognitive impairments among children with psychiatric disorders: Diagnosis and situational specificity
43. Effects of methylphenidate dosage in hyperactive reading-disabled children: II Reading achievement
44. Increased methylphenidate usage for attention deficit disorder in the 1990s
45. A survey of medication treatment for hyperactive/inattentive students
46. More frequent diagnosis of attention deficit-hyperactivity disorder
47. Validation of an index of the quality of review articles
48. Empirically supported psychosocial treatments for attention deficit hyperactivity disorder
49. Issues in comparisons between meta-analyses and large trials
50. Is acupuncture effective for the treatment of chronic pain? A systematic review
51. The importance of quality of primary studies in producing unbiased systematic reviews
52. Lessons from large trials: The MTA study as a model for evaluating the treatment of childhood psychiaric disorder
53. In the wake of the MTA: Charting a new course for the study and treatment of children with attention-deficit hyperactivity disorder
54. Short term effects of methylphenidate on the cognitive, learning and academic performance of children with attention deficit disorder in the laboratory and the classroom
55. Methylphenidate in hyperactive children: Differential effects of dose and mastery level on children's learning performance
56. Dose-response effects of methylphenidate on academic performance and overt behavior in hyperactive children
57. Patients' preferences and randomized trials